Arcellx (ACLX) Cash from Operations (2021 - 2025)
Arcellx (ACLX) recorded quarterly Cash from Operations of 58175000.0 in Q4 2025, down 18.23% quarter-over-quarter from 49207000.0 in Q3 2025, and down 26.38% on a YoY basis from 79025977.57 in Q4 2024.
Arcellx (ACLX) Cash from Operations (2021 - 2025) Analysis & Trends
Arcellx's Cash from Operations history runs 5 years deep, the most recent figure standing at 58175000.0 for Q4 2025.
- In Q4 2025, Cash from Operations fell 26.38% year-over-year to 58175000.0; the TTM figure through Dec 2025 stood at 210258000.0 (down 151.91% YoY), while the FY2025 annual figure was 210258000.0, down 151.91% from the prior year.
- Cash from Operations was 58175000.0 for Q4 2025 at Arcellx, down from 49207000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 182042000.0 in Q1 2023 to a low of 63145000.0 in Q1 2025.
- Historically, Cash from Operations has averaged 11984650.0 across 5 years, with a median of 22581500.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Cash from Operations jumped 658.65% in 2023, then plunged 260.18% in 2025.
- A 5-year view of Cash from Operations shows it stood at 21546000.0 in 2021, then declined by 27.73% to 27520000.0 in 2022, then surged by 311.66% to 58248000.0 in 2023, then plunged by 179.02% to 46030000.0 in 2024, then fell by 26.38% to 58175000.0 in 2025.
- The last three Cash from Operations figures came in at 58175000.0 (Q4 2025), 49207000.0 (Q3 2025), and 39731000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | -58.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -58.18 Mn |
| Dec 31, 2025 | -58.18 Mn |
| Sep 30, 2025 | -49.21 Mn |
| Sep 30, 2025 | -49.21 Mn |
| Jun 30, 2025 | -39.73 Mn |
| Jun 30, 2025 | -39.73 Mn |
| Mar 31, 2025 | -63.15 Mn |
| Mar 31, 2025 | -63.15 Mn |
| Dec 31, 2024 | -46.03 Mn |
| Dec 31, 2024 | -46.03 Mn |
| Sep 30, 2024 | 30.72 Mn |
| Sep 30, 2024 | 30.72 Mn |
| Jun 30, 2024 | -36.25 Mn |
| Jun 30, 2024 | -36.25 Mn |
| Mar 31, 2024 | -31.91 Mn |
| Mar 31, 2024 | -31.91 Mn |
| Dec 31, 2023 | 58.25 Mn |
| Dec 31, 2023 | 58.25 Mn |
| Sep 30, 2023 | -10.10 Mn |
| Sep 30, 2023 | -10.10 Mn |